Evaluating the Impact of EnteraGam In People With COVID-19
NCT04682041
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Covid19
Interventions
DIETARY_SUPPLEMENT:
Bovine Plasma-Derived Immunoglobulin Concentrate
OTHER:
Standard of care
Sponsor
Entera Health, Inc
Collaborators
[object Object]
[object Object]